Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations with Treatment Resistance in Clear Cell and Nonclear Cell Tumors. jkcvhl. 2025;12(2):37-45. doi:10.15586/jkcvhl.v12i2.386